INDIVIDUAL PEPTIDES
Heptapeptide-7 is a peptide candidate for facial and body texture-care formulations. Compare the individual peptide with multi-component reference preparations before selecting a supplied form and requesting documents, a laboratory sample or a quotation.
On this page Overview Identity Review Questions Enquire →
- Catalogue reference
- KI-017
- Product family
- Individual peptides
- CAS reference
- Confirm for the exact supplied material
- Public INCI identity reference
- Heptapeptide-7
The public overview identifies the catalogue material. Confirm the supplied grade, full composition and current batch specifications in the supplier documents.
Development directions
Facial or body texture and crepey-appearance concepts: specify the target area and visible endpoint. Supplier positioning for a prepared heptapeptide ingredient is a starting reference, not proof of the result of this individual material or your formula.
Possible formulation formats
- Body texture-care lotion evaluation
- Facial age-care emulsion
- Neck and body appearance-care serum development
Formulation concepts for evaluation. Review the actual supplied material and finished formula for the intended cosmetic use.
Identity and supplied form
The supplier reference describes MGRNIRN as the seven-residue sequence. This catalogue publishes no CAS. Request confirmation of terminal form, counterions, peptide content and full composition; the name alone does not identify a complete commercial preparation.
The body-care reference includes a delivery preparation
Grant’s supplier-owned listing positions Gransome Heptapeptide-7 for facial and body appearance care and describes a vesicle delivery system. That is a preparation-specific development reference. Confirm the test material and method before using its data; a listed biological rationale does not establish human results for another peptide grade.
Compare the material for your brief
The reference declaration includes Heptapeptide-7 with carnosine, water, glycerin, propanediol, lecithin, xanthan gum and a preservation system. Compare both the co-active and the carrier contribution. The solid-content value of that preparation should not be read as its peptide content.
Formulation review priorities
| Review point | What to establish |
|---|---|
| Target area | Separate facial texture from body crepey-appearance endpoints and choose suitable assessment conditions. |
| Preparation comparison | Record carnosine, carriers and preservation as well as peptide content. |
| Identity confirmation | Request the complete structural identity because no CAS is specified here. |
Public reference sources
Grant supplier-owned listing: Gransome Heptapeptide-7 →
GENOPEP: public catalogue reference →
Reference review: 31 October 2026. These public sources describe identity, research or third-party preparations. Confirm the exact offered material and its current documents for your project.
Questions for your brief
- Is your brief facial, neck or body texture care?
- Are you comparing an individual peptide or a prepared delivery system?
- Which documents, sample quantity and destination are required?
Is an individual Heptapeptide-7 equivalent to Gransome?
Not on name alone. The reference is a multi-component preparation with carnosine and a delivery system. Compare composition, peptide content and evidence before substitution.
Does a solids percentage indicate the peptide percentage?
No. Non-volatile material can include carriers and other components. Obtain a peptide-specific content basis for a meaningful quotation or formulation comparison.
Related catalogue directions
Compare Palmitoyl Hexapeptide-14 →